Search Results - Kyle Doolan

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    1182 Bispecific GPRC5D antibodies with potent cell-killing activity against multiple myeloma by Benjamin Doranz, Joseph Rucker, Ileine Sanchez, Kyle Doolan, Breanna Tyrell, Anna Lobley, Hayley Roth, Alyssa Cunningham, Ross Chambers, Trevor Barnes, Nnenna Nwogu

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  2. 2

    1183 Development of CTIM-76, a highly specific Claudin 6 bispecific antibody by Kelly Byrnes-Blake, Kate Slovik, Joseph Rucker, Ileine Sanchez, Kyle Doolan, Breanna Tyrell, Anna Lobley, Nicholas Molino, Kristin Shema, Kyle Guldner, Hayley Roth, Alyssa Cunningham, Eric Butz, Stanley Roberts, Riley Payne, Ed Calamai, Ross Chambers

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  3. 3

    Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccine by Ariadna Grinyo-Escuer, Srikar Reddy, Agnes L. Chenine, J. Charles Whitbeck, Sonya Jacobsen, Allison Sheetz, Kyle Doolan, Diana M. Norden, Nolan Frey, Frederick W. Holtsberg, M. Javad Aman, Katja Fink, Michael S. Diamond, John S. Schieffelin, James E. Crowe, Jr., Edgar Davidson, Benjamin J. Doranz

    Published in Cell Reports (2025-08-01)
    Get full text
    Article


Search Tools: